Is APYX or CBLL more profitable?

Apyx Medical has a net margin of -14.78% compared to CeriBell's net margin of -63.51%. CeriBell's return on equity of -38.19% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% CeriBell -63.51% -38.19% -30.92%

Does the media favor APYX or CBLL?

In the previous week, Apyx Medical had 5 more articles in the media than CeriBell. MarketBeat recorded 12 mentions for Apyx Medical and 7 mentions for CeriBell. CeriBell's average media sentiment score of 0.68 beat Apyx Medical's score of 0.63 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive CeriBell 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor APYX or TCMD?

In the previous week, Apyx Medical had 7 more articles in the media than Tactile Systems Technology. MarketBeat recorded 12 mentions for Apyx Medical and 5 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.82 beat Apyx Medical's score of 0.63 indicating that Tactile Systems Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Tactile Systems Technology 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is APYX or BWAY more profitable?

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -14.78%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Brainsway 15.68% 12.28% 7.75%

Does the media prefer APYX or BWAY?

In the previous week, Apyx Medical had 8 more articles in the media than Brainsway. MarketBeat recorded 12 mentions for Apyx Medical and 4 mentions for Brainsway. Brainsway's average media sentiment score of 1.06 beat Apyx Medical's score of 0.63 indicating that Brainsway is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Brainsway 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to APYX or ANGO?

In the previous week, AngioDynamics had 5 more articles in the media than Apyx Medical. MarketBeat recorded 17 mentions for AngioDynamics and 12 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.63 beat AngioDynamics' score of -0.05 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive AngioDynamics 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is BBNX or APYX more profitable?

Apyx Medical has a net margin of -14.78% compared to Beta Bionics' net margin of -61.31%. Beta Bionics' return on equity of -26.30% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Beta Bionics -61.31% -26.30% -23.25% Apyx Medical -14.78% -76.60% -13.91%

Does the media refer more to BBNX or APYX?

In the previous week, Apyx Medical had 9 more articles in the media than Beta Bionics. MarketBeat recorded 12 mentions for Apyx Medical and 3 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.80 beat Apyx Medical's score of 0.63 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apyx Medical 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Apyx Medical (APYX) Competitors

$3.46 -0.59 (-14.57%)

As of 04:00 PM Eastern

Compare

APYX vs. CBLL, TCMD, BWAY, ANGO, and BBNX

Should you buy Apyx Medical stock or one of its competitors? MarketBeat compares Apyx Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apyx Medical include CeriBell (CBLL), Tactile Systems Technology (TCMD), Brainsway (BWAY), AngioDynamics (ANGO), and Beta Bionics (BBNX). These companies are all part of the "healthcare equipment" industry.

How does Apyx Medical compare to CeriBell?

Apyx Medical (NASDAQ:APYX) and CeriBell (NASDAQ:CBLL) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Apyx Medical has higher earnings, but lower revenue than CeriBell. Apyx Medical is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A
CeriBell	$89.06M	8.22	-$53.41M	-$1.63	N/A

Apyx Medical currently has a consensus target price of $6.60, indicating a potential upside of 90.75%. CeriBell has a consensus target price of $22.20, indicating a potential upside of 15.03%. Given Apyx Medical's higher possible upside, equities research analysts clearly believe Apyx Medical is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

55.3% of Apyx Medical shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 17.7% of CeriBell shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Apyx Medical had 5 more articles in the media than CeriBell. MarketBeat recorded 12 mentions for Apyx Medical and 7 mentions for CeriBell. CeriBell's average media sentiment score of 0.68 beat Apyx Medical's score of 0.63 indicating that CeriBell is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
CeriBell	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has a net margin of -14.78% compared to CeriBell's net margin of -63.51%. CeriBell's return on equity of -38.19% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
CeriBell	-63.51%	-38.19%	-30.92%

Apyx Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, CeriBell has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

Summary

Apyx Medical beats CeriBell on 8 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Tactile Systems Technology?

Apyx Medical (NASDAQ:APYX) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Apyx Medical presently has a consensus target price of $6.60, suggesting a potential upside of 90.75%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 32.46%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts clearly believe Apyx Medical is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

In the previous week, Apyx Medical had 7 more articles in the media than Tactile Systems Technology. MarketBeat recorded 12 mentions for Apyx Medical and 5 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.82 beat Apyx Medical's score of 0.63 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Tactile Systems Technology	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A
Tactile Systems Technology	$329.52M	2.00	$19.09M	$0.88	33.11

Tactile Systems Technology has a net margin of 5.91% compared to Apyx Medical's net margin of -14.78%. Tactile Systems Technology's return on equity of 9.70% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Tactile Systems Technology	5.91%	9.70%	7.53%

Summary

Tactile Systems Technology beats Apyx Medical on 9 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Brainsway?

Apyx Medical (NASDAQ:APYX) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Apyx Medical had 8 more articles in the media than Brainsway. MarketBeat recorded 12 mentions for Apyx Medical and 4 mentions for Brainsway. Brainsway's average media sentiment score of 1.06 beat Apyx Medical's score of 0.63 indicating that Brainsway is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Brainsway	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical currently has a consensus price target of $6.60, indicating a potential upside of 90.75%. Brainsway has a consensus price target of $15.67, indicating a potential upside of 2.26%. Given Apyx Medical's higher probable upside, equities research analysts plainly believe Apyx Medical is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Brainsway	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Brainsway has a net margin of 15.68% compared to Apyx Medical's net margin of -14.78%. Brainsway's return on equity of 12.28% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Brainsway	15.68%	12.28%	7.75%

Apyx Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market.

Brainsway has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A
Brainsway	$52.22M	11.77	$7.57M	$0.35	43.77

Summary

Brainsway beats Apyx Medical on 11 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to AngioDynamics?

Apyx Medical (NASDAQ:APYX) and AngioDynamics (NASDAQ:ANGO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

AngioDynamics has a net margin of -11.48% compared to Apyx Medical's net margin of -14.78%. AngioDynamics' return on equity of -5.73% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
AngioDynamics	-11.48%	-5.73%	-3.77%

Apyx Medical has higher earnings, but lower revenue than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A
AngioDynamics	$320.17M	2.03	-$36.74M	-$0.87	N/A

Apyx Medical presently has a consensus price target of $6.60, indicating a potential upside of 90.75%. AngioDynamics has a consensus price target of $19.50, indicating a potential upside of 23.81%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Apyx Medical is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, AngioDynamics had 5 more articles in the media than Apyx Medical. MarketBeat recorded 17 mentions for AngioDynamics and 12 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.63 beat AngioDynamics' score of -0.05 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
AngioDynamics	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Apyx Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.33, suggesting that its share price is 67% less volatile than the broader market.

Summary

Apyx Medical beats AngioDynamics on 10 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Beta Bionics has a beta of 3.13, meaning that its stock price is 213% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Beta Bionics presently has a consensus price target of $20.10, suggesting a potential upside of 22.56%. Apyx Medical has a consensus price target of $6.60, suggesting a potential upside of 90.75%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

In the previous week, Apyx Medical had 9 more articles in the media than Beta Bionics. MarketBeat recorded 12 mentions for Apyx Medical and 3 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.80 beat Apyx Medical's score of 0.63 indicating that Beta Bionics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beta Bionics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Apyx Medical has lower revenue, but higher earnings than Beta Bionics. Apyx Medical is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	7.36	-$73.20M	-$1.65	N/A
Apyx Medical	$52.84M	2.76	-$11.21M	-$0.20	N/A

55.3% of Apyx Medical shares are held by institutional investors. 5.3% of Beta Bionics shares are held by company insiders. Comparatively, 15.9% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Apyx Medical has a net margin of -14.78% compared to Beta Bionics' net margin of -61.31%. Beta Bionics' return on equity of -26.30% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-61.31%	-26.30%	-23.25%
Apyx Medical	-14.78%	-76.60%	-13.91%

Summary

Apyx Medical beats Beta Bionics on 10 of the 17 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$145.74M	$5.79B	$7.05B	$12.94B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-17.30	24.71	269.76	24.76
Price / Sales	2.76	67.65	651.81	108.50
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	8.87	6.21	11.28	6.42
Net Income	-$11.21M	$147.87M	$3.45B	$347.27M
7 Day Performance	-17.22%	3.42%	3.61%	2.52%
1 Month Performance	-21.00%	1.70%	-0.53%	-1.00%
1 Year Performance	58.72%	6.22%	77.55%	23.29%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	3.27 of 5 stars	$3.46 -14.6%	$6.60 +90.8%	+85.8%	$145.74M	$52.84M	N/A	270	Earnings Report Gap Down
CBLL CeriBell	2.4236 of 5 stars	$18.52 +1.1%	$22.20 +19.9%	+45.7%	$694.73M	$89.06M	N/A	N/A	News Coverage
TCMD Tactile Systems Technology	3.7666 of 5 stars	$30.14 +1.2%	$38.60 +28.1%	+140.2%	$671.72M	$329.52M	34.25	1,086
BWAY Brainsway	3.8976 of 5 stars	$15.80 -0.1%	$15.67 -0.8%	+163.6%	$634.47M	$52.22M	45.14	120	Positive News Upcoming Earnings
ANGO AngioDynamics	3.3285 of 5 stars	$15.19 +0.1%	$19.50 +28.4%	+84.4%	$627.01M	$320.17M	N/A	760

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. CBLL, TCMD, BWAY, ANGO, and BBNX

How does Apyx Medical compare to CeriBell?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Summary

How does Apyx Medical compare to Brainsway?

Summary

How does Apyx Medical compare to AngioDynamics?

Summary

How does Apyx Medical compare to Beta Bionics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. CBLL, TCMD, BWAY, ANGO, and BBNX

How does Apyx Medical compare to CeriBell?

Which has better valuation and earnings, APYX or CBLL?

Do analysts rate APYX or CBLL?

Do institutionals & insiders believe in APYX or CBLL?

Does the media favor APYX or CBLL?

Is APYX or CBLL more profitable?

Which has more risk & volatility, APYX or CBLL?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Do analysts rate APYX or TCMD?

Which has more risk and volatility, APYX or TCMD?

Does the media favor APYX or TCMD?

Do insiders and institutionals have more ownership in APYX or TCMD?

Which has higher valuation and earnings, APYX or TCMD?

Is APYX or TCMD more profitable?

Summary

How does Apyx Medical compare to Brainsway?

Do insiders & institutionals have more ownership in APYX or BWAY?

Does the media prefer APYX or BWAY?

Do analysts rate APYX or BWAY?

Is APYX or BWAY more profitable?

Which has more risk & volatility, APYX or BWAY?

Which has higher earnings and valuation, APYX or BWAY?

Summary

How does Apyx Medical compare to AngioDynamics?

Is APYX or ANGO more profitable?

Which has preferable earnings & valuation, APYX or ANGO?

Do analysts rate APYX or ANGO?

Do institutionals & insiders believe in APYX or ANGO?

Does the media refer more to APYX or ANGO?

Which has more risk & volatility, APYX or ANGO?

Summary

How does Apyx Medical compare to Beta Bionics?

Which has more risk & volatility, BBNX or APYX?

Do analysts prefer BBNX or APYX?

Does the media refer more to BBNX or APYX?

Which has stronger valuation & earnings, BBNX or APYX?

Do insiders and institutionals have more ownership in BBNX or APYX?

Is BBNX or APYX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools